Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is dabrafenib mesylate msn patent issue?When will latisse patent expire?Patent expiry trametinib?When genetic tenofovir alafenamide be available in us?Abbvie humira patent cliff navigation success?
See the DrugPatentWatch profile for dupixent
Dupixent generated $1.3 billion in net product sales in 2019 [1]. In 2019, Regeneron reported these regional sales: - United States: $799 million [1] - Europe: $296 million [1] - Japan: $174 million [1]
Dupixent generated $2.1 billion in net product sales in 2020 [1]. In 2020, Regeneron reported these regional sales: - United States: $1.1 billion [1] - Europe: $591 million [1] - Japan: $276 million [1]
Net product sales rose from $1.3 billion in 2019 to $2.1 billion in 2020 [1]. That’s an increase of about $0.8 billion year over year.
Other Questions About Dupixent :